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Emergency physicians are frequently faced with making decisions regarding how aggressive to be in 
caring for critically ill patients. We aimed to identify factors that influence decisions to limit 
treatment in the Emergency Department through a systematic search of the available literature.  
Design 
Prospectively registered systematic review of  studies employing any methodology to investigate 
factors influencing decisions to limit treatment in the Emergency Department. Medline and EMBASE 
were searched from their inception until January 2019. Methodological quality was assessed using 
the Mixed Methods Appraisal Tool, but no studies were excluded based on quality. Findings were 
summarised by narrative analysis.  
Results 
10 studies published between 1998 and 2016 were identified for inclusion in this review, including 7 
cross-sectional studies investigating factors associated with treatment-limiting decisions, 2 surveys 
of physicians making treatment-limiting decisions and 1 qualitative study of physicians making 
treatment-limiting decisions. There was significant heterogeneity in patient groups, outcome 
measures, methodology, and quality. Only three studies received a methodology-specific rating of 
‘high quality’. Important limitations of the literature include the use of small single-centre 
retrospective cohorts often lacking a comparison group, and survey studies with low response rates 
employing closed-response questionnaires. Factors influencing treatment-limiting decisions were 
categorised into ‘patient and disease factors’ (age, chronic disease, functional limitation, patient and 
family wishes, comorbidity, quality of life, acute presenting disorder type, severity, and reversibility), 
‘hospital factors’ (colleague opinion, resource availability), and ‘non-patient healthcare factors’ 
(moral, ethical, social, and cost factors).   
Conclusions 
Several factors influence decisions to limit treatment in the Emergency Department. Many factors 
are objective and quantifiable, but some are subjective and open to individual interpretation. This 
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Key Messages: 
What is already known on this subject: 
 Optimisation of end-of-life care in emergency patients remains an area of uncertainty and 
has been identified as a research priority by clinicians, patients, and carers.  
 Understanding the factors that influence  decisions to limit treatment is a first step in 
designing decision-making aids and educational interventions to improve care delivery. 
 
What this study adds: 
 In this systematic review of 10 applicable studies on this topic, we found that decisions to 
limit treatment in the Emergency Department are  influenced by patient and disease factors, 
hospital factors, and non-patient healthcare factors. 
 Resource availability, cost factors, and cultural factors were also shown to influence decision 
making, highlighting potential ethical issues in a group of patients who are often unable to 
directly participate in the decision-making process. 
 The variety of factors and influences suggest the need for a more standardized approach to 














Emergency Physicians (EPs) frequently face decisions concerning the institution of appropriate 
treatment for critically ill patients. [1] Developing a rational, consistent approach to these difficult 
decisions in the Emergency Department (ED) is becoming more important as developed countries face 
an ageing and increasingly multimorbid patient population. [2,3]  Furthermore, the optimisation of 
end-of-life care in emergency patients has been highlighted as one of the top five research priorities 
in a recent UK research priority setting partnership involving clinicians, patients, and carers. [4] 
This review focuses on decisions made when there is an advance recognition that certain 
interventions, settings or clinical contexts may not be  appropriate in a clinical situation.  In the UK, 
the phrase “Ceilings of Treatment” is in use, but this phrase is not  is not widely used in an international 
context or conclusively defined in the literature, especially within the context of Emergency Medicine. 
[5] These crucial decisions  to limit treatment should aim to maximise patient autonomy, enhance 
quality of life, improve patient and family experience of the care process, align with the wishes and 
beliefs of patients and family, and avoid the excessive allocation of limited resources to provide 
unwanted and futile life sustaining treatment. [6,7]  
Treatment-limiting decisions can be challenging and complex in the ED. Patients may present across 
the continuum from the end of a long illness with well-defined expectations and an established 
advance care plan, or they may present with a devastating illness of sudden onset that is irreversible 
and requires palliation. Similar decisions are commonplace in palliative and other inpatient medical 
settings, but  are usually made with reference to more detailed information. In the ED, decisions 
concerning patients who present with compromised physiology and multiple significant comorbidities 
often have to be made within narrow time-frames by physicians frequently lacking crucial information 
regarding patient wishes, medical history, pre-morbid state, a prior relationship with the patient’s 
family, and where the patients frequently lack capacity to make important decisions about their own 
care. [1,8–10] The availability of advance care plans remains low in this environment. [1,11–13]   
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Additionally, physicians face a wider challenge  in which the issue of death and dying requires patients 
and their families to confront deeply held societal norms. [14] 
Effective and appropriate decision-making can improve patient and family experience of the dying 
process and reduce the burden of unnecessary hospital stay on patients and healthcare systems. 
[7,15] However, despite the benefits of early ED-based identification of patients appropriate for end-
of-life care, there is significant uncertainty and variability in decision-making between physicians and 
units. [16–18] Recognising in advance the potential limits of any treatment is a part of this process, 
but many other factors may play into this decision.   
Understanding factors associated with these decisions could inform the creation of decision-making 
aids and educational interventions designed to improve care delivery. The aim of this systematic 
review is to identify factors affecting decisions to limit treatment in the ED.  
Methods 
Protocol and Registration 
Search criteria, inclusion and exclusion criteria, risk of bias assessment and data synthesis methods 
were  specified in advance and documented in the International prospective register of systematic 
reviews (PROSPERO), registration number: CRD42018094751. [19] Patients or the public were not 
involved in the design, conduct, reporting, or dissemination plans of this review. 
Search Strategy 
A search of studies published in English in Medline and EMBASE from their inception until January 
2019 was conducted using a structured strategy designed to answer the question ‘what factors 
influence decisions to limit treatment by Emergency Physicians for patients presenting to the ED?’. 
Search terms were identified from key word lists of related publications and developed empirically by 
the authors, according to recommendations from the PRISMA and MOOSE guidelines of systematic 
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searches of observational studies. [20,21] Appendices 1 and 2 outline the search algorithms employed. 
Reference lists of included studies were hand searched for additional papers.  
Study Selection and definitions 
Studies employing any methodology to explicitly investigate factors ED physicians stated influenced 
decisions to limit treatment, or reporting associations between patient or healthcare provider 
characteristics and treatment-limiting decisions were included. We considered any type of decision 
explicitly affecting the ‘highest’ level of intervention deemed appropriate by a medical team.    Studies 
where the full text could not be obtained following reasonable attempts to contact the authors were 
excluded, as were papers not featuring original research. Full exclusion criteria were prospectively 
outlined on PROSPERO. [19]  
Data extraction 
Data were extracted separately by NW and IS, and checked by DJL.  Extracted data included: author’s 
name, date and country in which the study was performed, type of study, patient group and sample 
size, main aims and outcome measures. Variables or characteristics found to influence decision-
making were recorded, with point estimates of association and measurements of statistical 
significance where applicable.  
Statistical analysis 
Heterogeneity in design, definition, and study populations precluded the use of meta-analytic 
techniques. Findings were instead tabulated and then summarised by detailed narrative analysis in 
accordance to the PRISMA checklist. [20]  
Quality assessment  
Each study included for data synthesis was quality assessed by NW and DJL separately using the Mixed 
Methods Appraisal Tool (MMAT). [22] Any discrepancies in quality assessment scores were discussed 
until a consensus was reached. MMAT is an effective and practical tool for the quality assessment of 
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quantitative, qualitative, or mixed methods studies within their methodological domain. It yields 
comparable quality ratings ranging from 0% (low quality) to 100% (high quality) based on four 
methodology-specific criteria. Its validity and reliability meet accepted standards and it has been pilot 
tested for reliability in systematic reviews. [23,24] Studies were not excluded from the review due to 
low quality scores - these were instead reported and discussed in the narrative synthesis.  
Results 
Search Results 
Following the removal of duplicates, 5448 references were retained. 5404 papers were excluded on 
initial title and abstract screening based on prospectively outlined exclusion criteria. [19]  The full texts 
of 44 eligible papers were read and reviewed by NW, IS and DJL. A further 35 studies were excluded. 
Disagreements between researchers were discussed until a consensus was reached. The reference 
lists of the nine full-text articles included were searched for additional eligible studies, and one 
additional study was identified for inclusion.  Finally, ten papers were included for data extraction and 
qualitative synthesis.  Figure 1 outlines the study selection process.   
Study Characteristics  
Characteristics of included studies are summarised in Table 1.  Seven cross-sectional studies, two 
survey studies, and one qualitative study were included. Settings included France, Belgium, Spain, 
Morocco, and Australia.  
There was considerable heterogeneity in patient groups, outcome measures and methodology. 
Cross-sectional methodologies included either patients who died in the ED (5 studies), where there 
was a clear decisions to limit treatment (1 study),  or elderly patients where patient and physician 
factors that were associated with a decision regarding limitation of treatment were identified (1 
study). [1,8,25–29] Of the seven cross-sectional studies, all but two (both De Decker et al. studies) also 
included surveys or interviews (Rodriguez-Molinero et al.) of physicians investigating the factors that 
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physicians felt influenced decision-making in real time. [1,8,25,26,29]  Two additional studies (Biegler 
et al. and Wong et al.) asked physicians to complete self-administered questionnaires featuring 
hypothetical scenarios. [30,31]  Finally, one qualitative study (Fassier et al.) employed participant 
observation and physician interviews at the ED-ICU interface. [12]  
Several studies were subject to important methodological limitations.  Two of the cross-sectional 
studies (Le Conte et al. 2004 and De Decker et al. 2012) were small, single-centre studies lacking 
a comparison group, precluding attempts at multivariate regression.  [8,30] Damghi et al. 
employed retrospective single-centre cross-sectional methodology susceptible to selection bias 
and confounding factors. [25] Among 5 cross-sectional studies that also included physician 
surveys, 4 used pre-specified criteria to determine the factors considered important by 
physicians, limiting the range of potential responses elicited, and how these were selected is 
mostly unclear. [1,8,25,26,29] Two survey-based papers (Biegler et al. and Wong et al.) and a 
cross-sectional study (Rodriguez-Molinero et al.) used hypothetical deteriorations of real 
patients or hypothetical scenarios to elicit decision-making. [26,30,31]. Five cross-sectional 
studies only recruited patients who died in the ED, potentially excluding a cohort of patients with 
treatment-limiting decisions who died elsewhere or survived to discharge without treatment 
escalation. [1,25,27–29] Finally, most cross-sectional studies only included patients for whom a 
treatment-limiting decision was made, resulting in the exclusion of patients where treatment-
limitation was debated, but full escalation was felt to be appropriate.  [1,8,25,27–29]   
Study Quality  
A structured assessment of quality contextualised by methodology using MMAT is reported in table 
2.  Of note, Biegler et al.’s survey exhibited limitations concerning sampling and response rate, 
whilst Wong et al.’s survey risked participation bias with a response rate of 13%.  [30,31] Given 
the relatively small number of studies selected and the narrative synthesis of results, no studies 
were excluded.    
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Table 2: Quality rating using the Mixed Methods Appraisal Tool (MMAT). Asterisk denotes achievement of criteria. 
 Studies 
 


































































































































Are Participants recruited in a way that minimizes selection bias? 
* *  * * * *    
Are measurements appropriate regarding the exposure/intervention 
and outcomes?  
* * * * * * *    
In the groups being compared, are the participants comparable, or do 
researchers take into account the difference between the groups?  
 * *  *      
Are there complete outcome data, and when applicable, and 
acceptable response rate, or an acceptable follow-up rate for cohort 
studies?  

























) Is the sampling strategy relevant to address the quantitative research 
question? 
        *  
Is the sample representative of the population understudy? 
          
Are measurements appropriate? 
       * *  
Is there an acceptable response rate? 











Are the sources of qualitative data relevant to address the research 
question? 
         * 
Is the process for analysing qualitative data relevant to address the 
research question? 
         * 
Is appropriate consideration given to how findings relate to the 
context in which the data were collected? 
         * 
Is appropriate consideration given to how findings relate to the 
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Table 1: characteristics of included studies 
Paper, 
country, year 
Type of Study Patient group, sample size Main Aim Main outcome measure 






All adult non-trauma patients for whom a 
decision to withhold (WH) or withdraw 
(WD) life sustaining treatment was made 
by senior ED staff between January 1998 
and September 1998. n=119 
Identifying clinical situations where 
life-support was 
withheld/withdrawn, and the criteria 
used by physicians to justify their 
decisions. 




Pre-defined criteria used to justify 
treatment withhold/withdraw 
decisions. 





sectional survey  
All patients who died over two 2-month 
periods in 2004 and 2005 across 174 EDs 
in France (171) and Belgium (3).  
n=2420 
Describing patients who died in the 
ED, studying the number of patients 
for whom a decision to limit life 
support was taken and describing 
the process leading to such 
decisions.   
Association between patient 
characteristics and decision to 
withhold/withdraw life support 
therapies, using multivariate 
logistic regression analysis. 
 
Pre-defined criteria used to justify 
treatment withhold/withdraw 
decisions. 






All patients who died in a Moroccan ED 
over a 5-month period in 2009. Patients 
with brain death or who died in transit to 
the ED were excluded.  
n=177 
Assessing the frequency of situations 
where life-support therapies were 
withheld/withdrawn and modalities 
for implementation of these 
decisions.  
Univariate analysis of patient 
characteristics significantly 
associated with treatment 
withhold/withdraw decisions. 
 
Multivariate logistic regression of 
patient characteristics associated 
with treatment withhold/withdraw 
decisions.  
 












Elderly patients (older than 80 years or 
65-79 years with at least 2 
comorbidities), their physicians and their 
relatives, across 4 EDs over 5 months in 
2003 in Spain. Decisions based on 
patient/relative preferences, or on moral 
issues were excluded from multivariate 
analysis. n=101 
Analysing the elements that 
compose the emergency physicians' 
criterion for selecting elderly 
patients for intensive care 
treatment. 
Multivariate logistic regression of 
factors affecting treatment-
limitation decisions regarding 
CPR/ICU/CCU 
 
Physician-reported criteria used to 
justify treatment 
withhold/withdraw decisions as 
advance directives. 






All patients ≥65 years old who died over 
two 2-month periods in 2004 and 2005 
across 174 EDs in France (171) and 
Belgium (3).  
n=2095 
Determining whether the Charlson 
Comorbidity Index was associated 
with treatment-limiting decisions 
made for older patients who die in 
EDs.  
Univariate analysis of patient 
characteristics associated with 
treatment-limiting decisions. 
 
Multivariate logistic regression of 
patient characteristics associated 
with treatment-limiting decisions. 





study of patients who 
died in ED 
All patients who died in one ED in France 
between April 2008 and September 2009 
were retrospectively included. n=184 
Determining whether the Kaplan 
Feinstein Index score was associated 
with treatment-limiting decisions in 
older adults dying in the ED. 
Univariate analysis of patient 
characteristics associated with 
treatment-limiting decisions. 
 
Association between KFI score and 
treatment-limiting decisions on a 








based case series of 
deaths in the ED.  
Every adult or child who died in 6 EDs in 
Australia with a decision to 
withdraw/withhold made solely by 
Emergency Physicians (EPs) or Emergency 
Registrars (ERs), n=320.  
Describing differences between EPs 
and ERs in the importance placed on 
factors influencing withholding or 
withdrawing life-sustaining 
healthcare  
Frequency of factors and 
discussions being reported as very 
important by EPs and ERs when 
making decisions to withhold or 
withdraw life-sustaining healthcare 
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Biegler et al., 
Australia, 
1998[30] 
Survey based on a 
hypothetical scenario. 
All Emergency Physicians in Victoria, 
Australia. n=46 (67% of 69) 
Determining which factors most 
influence Emergency Physicians’ 
decisions to institute or withhold 
intubation for a hypothetical patient 
with life threatening illness. (closed 
responses) 
Factors regarded as important in 
the initial decision on whether to 
intubate or not. 
 
Factors causing reversal of initial 
decision.  
Wong et al., 
Australia, 
2012[31] 
Survey based on 
hypothetical scenarios. 
Members of the Australian College for 
Emergency Medicine residing in Australia 
or New Zealand. n=388 (13% of 2992) 
Identifying the decisions and 
attitudes of emergency clinicians in 
hypothetical scenarios involving 
advance directives. (closed 
responses) 
Factors influencing decisions on 
commencing full treatment, 
limiting treatment, or palliation in 
three hypothetical scenarios 
involving advance directives.  
 








Physicians observed making ED end-of-
life decisions for elderly patients were 
identified and interviewed in 2010 in 2 
hospitals in France. n=24 (15 ED and 9 
ICU physicians) 
Exploring physicians’ perceptions 
and attitudes toward triage and end-
of-life decisions for elderly critically 
ill patients at the ED-ICU interface.  
Themes and axial codes identified 




Table 3:  Cross sectional studies:  Variables associated with decisions to limit treatment in the ED.  
S = statistically significant association.  D = descriptive statistics used only. N = tested but no 











































































































Age D S S S S N - 
Chronic Disease D S* S† S‡ S‡N§ - - 
Acute presenting disorder D¶ S# S** - S†† S§§ - 
Functional limitation  D S - S S N - 
Patient wishes D D D - - D - 
Family wishes  D D D - - D - 
High illness severity  D - S - S - - 
Comorbidity  - - S - S N - 
Living in a long-term care facility - - - - S N - 












Discussion with nursing staff D D D - - - - 
Discussion with other ED physicians D D D - - - - 
Discussion with hospital specialist - D - - - - - 
Discussion with GP - D - - - - - 
Physician grade - - - - - - S 
Long stay in the ED before death - - - - - D - 
* Chronic disease, chronic immunodeficiency, chronic liver disease 
† Chronic disease, chronic cardiovascular disease, chronic malignancy 
‡ Chronic disease, chronic neuropsychiatric disease 
§ Chronic cardiovascular disease, malignancy, chronic metabolic, chronic respiratory disease  
¶ Acute neurological, respiratory, cardiovascular, gastrointestinal, cancer disorders 
# Acute neurological, respiratory, cardiovascular, brain haemorrhage, trauma disorders 
** Acute neurological disorders 
†† Acute neurological, respiratory, renal, haematologic disorders 









Table 4:  Cross sectional and survey studies: physician-reported criteria influencing decisions to limit treatment in 
































































































Age D D D D D D - 
Underlying chronic disease  D D D - - D - 
Acute presenting disorder D D N D - - - 
Irreversibility of acute disorder in first 24h D D D - - D - 
Previous functional limitation - D D D - D - 
Patient wishes D - - D D D - 
Family wishes  D - - D D D - 
Comorbidities - - - D D - D 
Underlying disease expected to be fatal within 6 months D D N - - - - 
Level of care considered maximal  D D D - - - - 
Expected poor post-morbid quality of life  D D D - - - - 
Pre-morbid quality of life - - - D - D - 
Absence of improvement following active treatment - D D - - - - 
Prior mental status - - - D - - D 
Presence of advance directive - - - - D - D 
High severity of illness  D - - - - - - 
On home oxygen - - - - - D - 
Nursing home resident - - - - - D - 
Severe dementia - - - - - D - 
Prognosis - - - - D - - 
Physician perception of patient’s interests - - - - D - - 











 Discussion with ICU - - - - D - - 
ICU bed availability - - - - D - - 






















 High cost of care - - D - - - - 
Moral considerations - - - D - - - 
Ethical and professional responsibility - - - - - - D 
Social status - - - D - - - 
Organ donation - - - - D - - 
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The studies identified in this review generally assessed two outcome measures: association of 
measured variables with treatment-limiting decisions (Table 3);  in other words ‘who are these 
decisions made for’,  and factors reported by Emergency Physicians as influencing these decisions 
(Table 4) - and ‘how do we think we made these decisions?’. Factors can be loosely grouped into 
‘patient and disease factors’, ‘hospital factors’, and ‘non -patient healthcare factors’. Consistent 
findings are described below, including a summary of the statistical analyses undertaken. The purely 
qualitative study is described narratively. 
Factors affecting decisions to limit treatment in cross sectional and survey studies: 
Age 
Five of the cross-sectional studies demonstrated an  association between age and decisions to limit 
treatment. [1,8,25,26,28] In the most robust prospective multicentre cross-sectional study, Le Conte 
et al. (2010) found age to be independently associated with decisions to withhold or withdraw care 
in the ED  through multivariate logistic regression analysis of 2420 patients who died in 174 EDs (71–
81yrs OR=1.60 [95% CI: 1.18–2.16], 81–88yrs OR=2.51 [95%CI: 1.78–3.52], >88yrs OR=3.27 [95%CI: 
2.26–4.71]). [1] Three other cross-sectional studies demonstrated statistical association between age 
and treatment-limiting decisions: De Decker et al. (age ≥85 years OR=20.33 [95% CI: 3.86-107.20]), 
Damghi et al. (OR = 1.1 [95% CI = 1.01-1.07]), Rodriguez-Molinero  (OR 0.76 [95% CI: 0.59-0.97]). 
[25,26,28] A second study by De Decker et al. failed to demonstrate statistical association between 
age and decisions to limit treatment; however,  this study included older adult patients only (mean 
age 86  6). [27]  
Age was self-reported as influencing 24% to 43% of decisions to limit treatment made by surveyed 




Decisions to limit treatment were often associated with the presence of chronic disease. Le Conte et 
al. (2010) found that  chronic immunodeficiency (OR= 1.90 [95% CI: 1.10-3.28]), liver disease (OR= 
2.18 [95% CI: 1.43-3.31]) and metastatic cancer (OR= 2.34 [95% CI: 1.56-3.52]) influenced decisions 
to limit treatment. [1] Damghi et al. found association with underlying malignancy (OR = 3.4 [95% CI: 
2.06-28.55]) and chronic heart failure (OR = 7.7 [95% CI: 1.38-8.54]). [25] De Decker et al. showed 
association between chronic diseases with functional impairment and treatment-limiting decisions 
on univariate analysis (p=0.009), but did not demonstrate significant association between these 
decisions and underlying malignancy or cardiovascular disease, in contrast with Damghi et al. [28]. 
Chronic respiratory disease appeared to be an independent factor inversely associated with 
treatment-limiting decisions in the De Decker study (OR= 0.17 [95% CI: 0.03-0.97]). [28] 
Chronic debilitating disease was an important consideration by Emergency Physicians when making 
treatment-limiting decisions in 22%  (Le Conte et al. 2010), 35% (Le Conte et al. 2004), 32% (Damghi 
et al.), and 61% (Biegler et al.) of cases. [1,8,25,30] 
Acute presenting disorder 
Decisions to limit treatment were commonly associated with acute neurological and respiratory 
presenting disorders. [1,8,25,27,28] Respiratory acute presenting disorders were found to be 
independently associated with decisions by Le Conte et al. (2010) (OR = 1.61 [95% CI: 1.21-2.13]), and 
De Decker et al. (OR = 7.89 [95% CI: 1.40-44.33]). [1,28] Acute neurological presenting disorders  were 
found to be associated with decisions to limit treatment by Le Conte et al. (2010) (OR = 1.91 [95% CI 
= 1.39-2.62]), De Decker et al. (OR = 16.12 [95% CI = 2.70-96.07]), and Damghi et al. (OR = 4.1 [95% CI 
= 1.48-11.68]). [1,25,27] In contradiction to this,  De Decker et al. found neurological causes of organ 
failure to be inversely associated with decisions to limit treatment (OR = 0.2 [95% CI = 0.06-0.68]. [28] 
Treatment-limiting decisions were associated with a number of other acute presenting disorders in 
individual studies, but less frequently  tested  overall  (Table 3).  
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“Principal acute presenting medical disorder” was the most frequently cited factor affecting treatment 
escalation decisions in two studies that performed surveys of physicians, influencing 77% and 83% of 
decisions to withhold or withdraw treatment. “Underlying disease expected to  be fatal within 6 
months” also influenced 20% and 37% of decisions in the same studies. [1,8] In their survey of 
physicians, Rodriguez-Molinero et al. found that the  presenting medical disorder influenced 18% of 
decisions regarding continuance of cardiopulmonary resuscitation or admission to intensive care 
units. [26] Of note, no physicians chose “acute presenting disorder” or “underlying disease expected 
to be fatal within 6 months” from a pre-defined list of factors influencing treatment limitation of 54 
patients who died in ED in Damghi et al.’s survey. [25] 
Functional limitation 
Le Conte et al.’s (2004) cohort of patients for whom a treatment-limiting decision was made were 
severely functionally limited in 53% of cases. [8]  Le Conte et al. (2010) showed that severe functional 
limitation  was independently associated with decisions to withhold or withdraw treatment (Knauss C 
OR= 3.54 [95% CI: 2.66-4.70]), Knauss D OR= 5.84 [95% CI: 3.94-8.66]). [1] Rodriguez-Molinero et al. 
found functional limitation as assessed by physicians to be associated with decisions to limit treatment 
(p<0.001). [26] De Decker et al. showed significant association between functional limitation and  
decisions to limit treatment (p<0.001) in one study, but failed to show significant association in 
another, smaller study. [27,28]  
Prior functional limitation was used by physicians in considering 38% (Le Conte et al. 2010), 69% 
(Rodriguez-Molinero et al.) and 6% (Damghi et al.) of treatment-limitation decisions. [1,25,26] 
Functional status was considered important in 85% of decisions to intubate (Biegler et al.). [30]  
Patient and Family wishes 
Four cross-sectional studies included in this review described patient and family involvement in 
decisions to withhold or withdraw treatment. [1,8,25,27]  Le Conte et al. (2010) reported that of 2420 
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patients who died in 174 EDs, only 8% had capacity to participate in decision-making (of which 32% 
were ultimately involved). Family was involved in decision-making in 58% of cases. [1] Similarly, 
Damghi et al. showed patient and family involvement of 11% and 27%, De Decker et al. 13% and 37%, 
and Le Conte et al. (2004) of 27% and 72%. [1,25,28] 
Patient wishes influenced 2%, 8%, 32%, and 63% of treatment-limiting decisions in studies by 
Rodriguez-Molinero et al, Le Conte et al (2004)., Richardson et al., and Biegler et al. respectively. 
[8,26,29,30] Wong et al. found that the introduction of an Advance Directive expressing treatment-
limiting wishes to hypothetical scenarios significantly impacted decisions to limit treatment. [31] 59% 
of physicians in Richardson et al.’s survey reported Advance Directives influencing decision-making. 
[29] Family wishes were cited by Emergency Physicians as influencing 2%, 56%, and 90% of decisions 
in Rodriguez-Molinero et al., Biegler et al., and Richardson et al.’s studies, respectively. [26,29,30] 
High illness severity and Reversibility  
Decisions to limit treatment were frequently statistically associated with high illness severity. Damghi 
et al. showed association between higher APACHE II scores and decisions to limit treatment (p<0.001), 
whilst De Decker et al.  demonstrated association with 2 or more organ failures (p<0.001). [25,28] 
Perceived irreversibility of the acute presenting disorder was cited by Emergency Physicians as 
contributing factors in 54% (Le Conte et al. 2010), 60% (Le Conte et al. 2004), and 43% (Damghi et al.) 
of cases involving decisions to withhold or withdraw treatment. [1,8,25] Reversibility of illness was 
considered important in 98% of initial decisions to intubate (Biegler et al). [30] Physicians cited 
‘absence of improvement following a period of active treatment’ as influencing 26% and 61% of 
decisions to limit treatment in Le Conte et al. (2010) and Damghi et al.’s studies respectively. [1,25] 
High illness severity was reported as influential in 40% of decisions to limit treatment in Le Conte et 




Damghi et al. found that patients with treatment-limiting decisions had a higher Charlson Comorbidity 
Index (p<0.001), and a Charlson Comorbidity Index score of 5 or more was independently associated 
with treatment-limiting decisions (OR=25.56 [95% CI: 1.22-537.29] in one study by De Decker et al. 
[25,28]. De Decker et al. did not show significant association between severity of comorbidities (as 
measured by the Kaplan Feinstein Index) with treatment-limiting decisions in a smaller single-centre 
study. [27] Comorbidity was reported by physicians as influencing 30%, 37%, and 88% of decisions to 
limit treatment in Rodriguez-Molinero et al., Wong et al., and Richardson et al.’s studies, respectively. 
[26,29,31]  
Discussion with ED physicians and nursing staff 
Several studies reported involvement of ED physician and nursing colleagues in decision-making. Le 
Conte et al (2004) found that decisions to withhold or withdraw treatment were discussed with other 
medical and nursing staff in 39% and 31% of cases respectively. [8]  In Le Conte et al.’s 2010 paper, 
decisions were made by at least 2 ED physicians in 80% of cases, with nursing staff involvement in 
27%.[1] Damghi et al. found additional ED physicians involved in decision-making for 57% of cases and  
nursing staff involved in 89% of decisions. [25]  
Quality of life 
Poor predicted post-morbid quality of life was frequently cited in surveys of physicians. Le Conte et al. 
found that 39% and 25% of physicians considered this to be important in their 2004 and 2010 papers 
respectively. [1,8] Damghi et al. found that 33% considered quality of life to be influential. [25] 4% of 
physicians in Rodriguez-Molinero et al.’s paper cited pre-morbid quality of life as an important factor 
when making plans for treatment or therapeutic abstention concerning cardiopulmonary 
resuscitation or admission to intensive care units. [26] 83% of Biegler et al.’s respondents considered 
pre-morbid quality of life important when making decisions to intubate. [30]  
Current level of care maximal 
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Three studies also found that ‘current level of care considered maximal’, described as “when more 
aggressive therapy would be unreasonable”, was used to justify 17% (Le Conte et al. 2010), 59% (Le 
Conte et al. 2004) and 6% (Damghi et al.) of decisions to withhold or withdraw treatment. [1,8,25] 
Factors affecting treatment escalation decisions in qualitative studies: 
In Fassier et al.’s ED-based qualitative study of decisions to limit treatment using  non-participant 
observations and semi-structured interviews, a major theme was ‘physician’s representation of the 
elderly’. Physicians conceptualised ‘elderly’ through the lens of old-age thresholds (younger than 70  
years, 70-85 years, and over 85-years), physiological age as being either preserved or altered, and 
elderly stereotypes such as ‘the independent super-grandpa’ or ‘the senile nursing home resident 
with dementia’. Personal familial experience of ageing also was identified as influential. Decisions 
were influenced by family member’s wishes and were perceived as more straightforward when 
information about the patient’s end-of-life preferences was available. Younger physicians with no 
training in end-of-life decision-making perceived treatment-limiting decisions to be complex, 
describing a psychological burden associated with doubt, uncertainty, guilt, and regret over making 
‘life or death decisions.’ Experience and training in ICU and palliative care was perceived as making 
decisions easier.  Decisions to limit treatment were perceived as complex, time intensive, and 
complicated by nightshifts, weekends, and handovers. Lack of time and lack of a dedicated ‘relatives 
room’ made decisions more challenging in the ED. [12] 
Discussion 
Main findings 
Factors shown to influence decisions to limit treatment with consistency were broadly 
categorised into patient factors (age, chronic disease, functional limitation, comorbidity, quality 
of life), acute disease factors (type , severity, and reversibility of acute presenting disorder), and 
patient and family wishes. This was often in the context of discussion with medical and nursing 
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colleagues. There were several additional factors statistically associated with treatment-limiting 
decisions or considered important by physicians that were only reported in some papers, perhaps 
playing a more peripheral and context-dependent role in decision-making. 
The association of measured variables with treatment-limiting decisions and factors reported by 
Emergency Physicians as influencing these decisions were largely congruent across different 
studies. However, there were some discrepancies between statistically associated factors and those 
reported important by physicians. These may be due to recall and reporting bias, or may suggest that 
clinicians’ intentions do not always match their actions in practice, and that their actions may be 
influenced by external factors such as family wishes, legal considerations, societal norms.    
The included studies represented a variety of social, cultural and economic situations, all of 
which may have influenced the individual study findings. While many of the findings of individual 
studies may have been generalisable to other healthcare settings, questions regarding the impact 
of healthcare system, resource availability, and cultural factors remain. For example, the study 
conducted by Damghi et al. in Morocco (the only middle-income country included in this review) 
uniquely found ‘high cost of care’ to be a factor used by physicians to justify 15% of treatment 
withhold/withdraw decisions. Financial barriers have previously been described in foregoing or 
delaying access to emergency care services in low, middle and high-income countries. [32] 
Implications 
Some identified factors raise ethical questions regarding the influence of cultural norms and the 
healthcare models within which these decisions are made on the decision-making process. For 
example the finding that resource factors (high cost of care, ICU bed availability) and subjective 
factors open to inherent bias (moral considerations, patient’s interests,  perceived quality of life and 
functional status) may play a role in decision-making invites questions on the ethics of considering 
these influences, and may help to explain the previously observed inter-physician variability. [16–
18] The factor ‘poor predicted post-morbid quality of life’ is open to significant subjectivity and bias. 
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Furthermore, it assumes physicians can accurately predict outcome in critically ill patients. Physicians 
must be cognisant of the potential for bias when making decisions to limit treatment. This highlights 
the importance of a team approach to decision-making, and is perhaps an area in which clinical 
decision support can be beneficial. 
Furthermore, a large proportion of the patient cohort included in this review lacked capacity to 
participate in the decision-making process, highlighting the importance of advance care plans 
and scope for initiatives such as the ‘Recommended Summary Plan for Emergency Care and 
Treatment (ReSPECT)’ to enhance patient autonomy and improve the quality of decision-making in 
the ED setting. [33]  
This review highlights the complexity and need for more robust research to increase and validate 
our knowledge regarding the multitude of additional, less prevalent factors influencing 
treatment escalation decisions. Whilst commendable effort has been made to conduct high-
quality, multi-centre observational studies with prospective design and innovative data 
collection methodology in this challenging field, limitations such as the use of surveys featuring 
pre-defined criteria may limit the scope of factors elicited. Our findings highlight that qualitative 
research may have a significant role to play in elucidating factors which may be unpicked with 
difficulty through observational and survey-based methodology alone.  
Limitations 
This review had several limitations. Firstly, language bias may have been introduced as the search 
was restricted to studies available in English. There is also potential for bias arising from study 
setting as only one study was conducted in a middle-income country (Morocco). Of the other 
nine studies included, five were conducted in France (one partially conducted in Belgium), three 
in Australia, and one in Spain. This may reflect that end-of-life care in general is not a research 
priority in low to middle income countries at this time.  
23 
 
GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative Research) methodology was 
employed to assess confidence in the findings of this review (Appendix 1 and 2). [34] This evaluation 
was however severely limited as it is based on a single qualitative study. Due to the relatively small 
number of manuscripts identified for inclusion, methodological limitations identified through MMAT 
assessment, and heterogeneous methodology employed by the included studies, the level of 
confidence in the conclusions made by this review is low. This emphasises the importance of further 
research in this important topic.    
The review of this complex area of clinical practice benefited from a lack of methodology-specific 
exclusion criteria, resulting in the inclusion of several diverse study designs. However, this 
heterogeneity limited the ability for direct comparisons between studies or pooling of data in 
any meaningful manner. Furthermore, the variability of variables extracted for analysis and pre-
defined factors measured makes discerning relative frequency and comparing findings difficult. 
As a result, this review was unable to quantitatively analyse the results of included studies using 
a meta-analytic approach, instead employing narrative synthesis.  Lastly, this review did not seek 
to synthesise results based on weightings of quality. This may become a consideration as further 
work emerges.  
Conclusion 
This review highlights several factors affecting decisions to limit treatment. Some are objective and 
quantifiable, but others are subjective and open to individual interpretation. This raises potential 
ethical issues in the context of low patient and family participation in decision making.  
Practitioners should be aware of this subjectivity and their biases when asked to make these 
decisions. In light of these findings, it would be prudent of Emergency Physicians to involve the 
wider clinical team in decision-making, while striving to include patients and their families wherever 
possible and appropriate. 
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This review highlights the need for larger scale, methodologically robust studies on the factors 
influencing treatment escalation decisions in Emergency Medicine, particularly as the ageing of the 
population inevitably will make these kinds of decisions more commonplace in the ED. 
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